SAT0323 Adverse drug reactionsrelated to disease-modifying drugs (DMARD) in psoriatic arthritis patients in daily clinical practice

Simple item page
dc.contributor.authorD. Freites
dc.contributor.authorZulema Rosales
dc.contributor.authorLeticia León
dc.contributor.authorJ. Font
dc.contributor.authorP. Lois
dc.contributor.authorCristina Vadillo
dc.contributor.authorEsperanza Pato
dc.contributor.authorBenjamín Fernández‐Gutiérrez
dc.contributor.authorLuis Rodríguez‐Rodríguez
dc.contributor.authorJuan Ángel Jover
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T17:56:25Z
dc.date.available2026-03-22T17:56:25Z
dc.date.issued2018
dc.identifier.doi10.1136/annrheumdis-2018-eular.2577
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2018-eular.2577
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/67155
dc.language.isoen
dc.publisherBMJ
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.sourceFundación para el Desarrollo de la Ecología
dc.subjectMedicine
dc.subjectDiscontinuation
dc.subjectPsoriatic arthritis
dc.subjectInternal medicine
dc.subjectPsoriasis
dc.subjectRetrospective cohort study
dc.subjectHazard ratio
dc.subjectProportional hazards model
dc.subjectAdverse effect
dc.subjectRheumatoid arthritis
dc.titleSAT0323 Adverse drug reactionsrelated to disease-modifying drugs (DMARD) in psoriatic arthritis patients in daily clinical practice
dc.typearticle

Files

Collections

Artículo Científico Publicado